BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18932059)

  • 1. Development of biodegradable drug releasing polymeric cardiovascular stents and in vitro evaluation.
    Sarisözen C; Arica B; Hincal AA; Caliş S
    J Microencapsul; 2009 Sep; 26(6):501-12. PubMed ID: 18932059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine.
    Bae SE; Son JS; Park K; Han DK
    J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings.
    Westedt U; Wittmar M; Hellwig M; Hanefeld P; Greiner A; Schaper AK; Kissel T
    J Control Release; 2006 Mar; 111(1-2):235-46. PubMed ID: 16466824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin-C delivery from CoCr alloy surfaces using polymer-free and polymer-based platforms for cardiovascular stent applications.
    Thiruppathi E; Mani G
    Langmuir; 2014 Jun; 30(21):6237-49. PubMed ID: 24832897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin A palmitate and aciclovir biodegradable microspheres for intraocular sustained release.
    Martínez-Sancho C; Herrero-Vanrell R; Negro S
    Int J Pharm; 2006 Dec; 326(1-2):100-6. PubMed ID: 16945492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled release of amoxicillin from hydroxyapatite-coated poly(lactic-co-glycolic acid) microspheres.
    Xu Q; Czernuszka JT
    J Control Release; 2008 Apr; 127(2):146-53. PubMed ID: 18325617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes II: effect of degradation on targeting activity.
    Eniola AO; Hammer DA
    Biomaterials; 2005 Feb; 26(6):661-70. PubMed ID: 15282144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled release of sirolimus from a multilayered PLGA stent matrix.
    Wang X; Venkatraman SS; Boey FY; Loo JS; Tan LP
    Biomaterials; 2006 Nov; 27(32):5588-95. PubMed ID: 16879865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradable polymeric microspheres with "open/closed" pores for sustained release of human growth hormone.
    Kim HK; Chung HJ; Park TG
    J Control Release; 2006 May; 112(2):167-74. PubMed ID: 16542746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum.
    Kohane DS; Tse JY; Yeo Y; Padera R; Shubina M; Langer R
    J Biomed Mater Res A; 2006 May; 77(2):351-61. PubMed ID: 16425240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodegradable ibuprofen-loaded PLGA microspheres for intraarticular administration. Effect of Labrafil addition on release in vitro.
    Fernández-Carballido A; Herrero-Vanrell R; Molina-Martínez IT; Pastoriza P
    Int J Pharm; 2004 Jul; 279(1-2):33-41. PubMed ID: 15234792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, characterization and in vitro anticoagulation of emodin-eluting controlled biodegradable stent coatings.
    Pan CJ; Wang J; Huang N
    Colloids Surf B Biointerfaces; 2010 Jun; 77(2):155-60. PubMed ID: 20194006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
    Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
    Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings.
    Norton LW; Tegnell E; Toporek SS; Reichert WM
    Biomaterials; 2005 Jun; 26(16):3285-97. PubMed ID: 15603824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable stents with elastic memory.
    Venkatraman SS; Tan LP; Joso JF; Boey YC; Wang X
    Biomaterials; 2006 Mar; 27(8):1573-8. PubMed ID: 16181673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres.
    Zolnik BS; Burgess DJ
    J Control Release; 2008 Apr; 127(2):137-45. PubMed ID: 18282629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled-release implant system formulated using biodegradable hemostatic gauze as scaffold.
    Xu L; Wu F; Yuan W; Jin T
    Int J Pharm; 2008 May; 355(1-2):249-58. PubMed ID: 18249510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
    Berchane NS; Carson KH; Rice-Ficht AC; Andrews MJ
    Int J Pharm; 2007 Jun; 337(1-2):118-26. PubMed ID: 17289316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled release of bioactive doxorubicin from microspheres embedded within gelatin scaffolds.
    Defail AJ; Edington HD; Matthews S; Lee WC; Marra KG
    J Biomed Mater Res A; 2006 Dec; 79(4):954-62. PubMed ID: 16941588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.